18F-A1F-NOTA-FAPI-04 PET/CT can Predict Treatment Response and Survival in Patients with Inoperable Pancreatic Adenocarcinoma

被引:0
|
作者
Zhu, Z. [1 ]
Zhang, X. [2 ]
Zhang, Y. [3 ]
Hu, X. [4 ]
Yue, J. [5 ]
机构
[1] Weifang Med Univ, Weifang, Shandong, Peoples R China
[2] Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Shandong Canc Hosp, Jinan, Shandong, Peoples R China
[4] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Peoples R China
[5] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2788
引用
收藏
页码:E360 / E360
页数:1
相关论文
共 50 条
  • [1] [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
    Zhu, Ziyuan
    Cheng, Kai
    Yun, Zhang
    Zhang, Xiang
    Hu, Xiaoyu
    Liu, Jing
    Wang, Fuhao
    Fu, Zheng
    Yue, Jinbo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3425 - 3438
  • [2] [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
    Ziyuan Zhu
    Kai Cheng
    Zhang Yun
    Xiang Zhang
    Xiaoyu Hu
    Jing Liu
    Fuhao Wang
    Zheng Fu
    Jinbo Yue
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3425 - 3438
  • [3] [18F]AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
    Hu, X.
    Yu, J.
    Wei, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S225 - S225
  • [4] 18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma
    Li, Xiang
    Lu, Na
    Lin, Lili
    Chen, Yiwen
    Yang, Shuye
    Wang, Huatao
    Liu, Xinyuan
    Wu, Chengyi
    Xue, Xing
    Su, Xinhui
    Bai, Xueli
    Liang, Tingbo
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (02) : 206 - 212
  • [5] Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy
    Zhang, Yafei
    Xu, Mimi
    Wang, Yu
    Yu, Fang
    Chen, Xinxin
    Wang, Guangfa
    Zhao, Kui
    Yang, Hong
    Su, Xinhui
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 2118 - 2131
  • [6] Relapsing polychondritis revealed by 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT
    Ni, Ming
    Xie, Qiang
    Zhu, Xingxing
    Lv, Weifu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (01): : 108 - 110
  • [7] Clinical application of Al18F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to 18F-FDG
    Zhehao Lyu
    Wei Han
    Qi Zhang
    Hongyue Zhao
    Shan Liu
    Yan Wang
    Jin He
    Changjiu Zhao
    Lin Tian
    Peng Fu
    Cancer Imaging, 23 (1)
  • [8] Clinical application of Al18F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to 18F-FDG
    Lyu, Zhehao
    Han, Wei
    Zhang, Qi
    Zhao, Hongyue
    Liu, Shan
    Wang, Yan
    He, Jin
    Zhao, Changjiu
    Tian, Lin
    Fu, Peng
    CANCER IMAGING, 2023, 23 (01)
  • [9] Al18F-NOTA-FAPI PET/CT in the evaluation of gastric, liver, and pancreatic cancer and comparison with 18F-FDG PET/CT
    Xu, Weizhi
    Meng, Tinghua
    Pang, Yizhen
    Sun, Long
    Zhang, Jingjing
    Chen, Xiaoyuan
    Chen, Haojun
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [10] Value of 18F-FAPI-04 PET-CT for prediction of pathologic response and survival in locally advanced pancreatic ductal adenocarcinoma after neoadjuvant chemotherapy
    Zhang, Y.
    Xu, M.
    Wang, Y.
    Yu, F.
    Chen, X.
    Wang, G.
    Zhao, K.
    Su, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S239 - S240